Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Pituitary Tumor Surveillance: Pathogenic Correlation
This study is currently recruiting participants.
Verified by Cedars-Sinai Medical Center, January 2008
Sponsored by: Cedars-Sinai Medical Center
Information provided by: Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier: NCT00599092
  Purpose

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.


Condition
Pituitary Tumor

MedlinePlus related topics: Cancer
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Pituitary Tumor Surveillance: Pathogenetic Correlation

Further study details as provided by Cedars-Sinai Medical Center:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

whole blood


Estimated Enrollment: 1250
Study Start Date: January 1997
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Detailed Description:

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

tertiary referral center

Criteria

Inclusion Criteria:

  • patients with confirmed pituitary disease

Exclusion Criteria:

  • patients who do not have confirmed pituitary disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00599092

Locations
United States, California
Cedars-Sinai Medical Center, Pituitary Center Recruiting
Los Angeles, California, United States, 90048
Contact: Alexis Jacobs, RN, BSN     310-423-3395     Alexis.Jacobs@cshs.org    
Contact: Vivien Bonert, MD     310-423-2830     Vivien.Bonert@cshs.org    
Principal Investigator: Shlomo Melmed, MD            
Sponsors and Collaborators
Cedars-Sinai Medical Center
Investigators
Principal Investigator: Shlomo Melmed, MD Cedars-Sinai Medical Center, Pituitary Center
  More Information

Responsible Party: Cedars-Sinai Medical Center ( Shlomo Melmed, MD )
Study ID Numbers: 2873, 2873
Study First Received: January 11, 2008
Last Updated: January 11, 2008
ClinicalTrials.gov Identifier: NCT00599092  
Health Authority: United States: Institutional Review Board

Keywords provided by Cedars-Sinai Medical Center:
pituitary tumor
recurrence

Study placed in the following topic categories:
Hypothalamic Diseases
Pituitary Diseases
Central Nervous System Diseases
Endocrine System Diseases
Pituitary Neoplasms
Central Nervous System Neoplasms
Brain Diseases
Supratentorial Neoplasms
Recurrence
Brain Neoplasms
Endocrinopathy
Nervous System Neoplasms
Endocrine Gland Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Hypothalamic Neoplasms
Nervous System Diseases

ClinicalTrials.gov processed this record on January 14, 2009